Home About NCIRS Staff Research The facts Publications Links HomeAbout NCIRSStaffResearchThe factsPublicationsLinksNews + events

News

Message Stick Newsletter Oct 09

 

National meeting on pneumococcal disease, July 2009

- selected Powerpoint presentations now available below:

 

Should Aboriginal children get both pneumococcal vaccines? - by Amanda Leach

Pneumococcal epidemiology in the conjugate vaccine era - can non-vaccine serotype replacement in carriage predict disease serotypes? - by Amanda Leach

PCR in pneumococcal disease diagnosis (and surveillance) - by Lyn Gilbert

How well is the 23vPPV working in the non-Indigenous Elderly? - by Rob Menzies

How well is the 23vPPV working in Indigenous adults? - by Rob Menzies

 

Second Indigenous immunisation research workshop, July 2009

- selected Powerpoint presentations now available below:

 

A Systems Approach to Improving Immunisation Timeliness - by Ross Bailie

NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation - by Terry Nolan

Immunisation Priorities for OATSIH - by Dr Geetha Isaac-Toua

Immunisation issues – ACCHS perspectives - by Jenny Hunt

Centre for Clinical Research Excellence in Aboriginal Health:
Sexually transmitted and bloodborne viral infections
- by James Ward

Estimates of hepatitis B infection - by Nick Wood

Universal Paediatric Influenza Vaccination: The Western Australia ExperienceCredit - by Paul Effler

Immunisation of Indigenous people: Achievements and challenges - by Rob Menzies

Women, HPV, Indigenous, non-Indigenous Urban Rural study - by Telphia Joseph

 

NCIRS September Newsletter (click on image to open PDF)

 

NCIRS Biennial Report, 2008 (click on image to open PDF)

This report documents several significant achievements in policy support and surveillance, including full technical resourcing of the Australian Technical Advisory Group on Immunisation (ATAGI) for the Australian Immunisation Handbook and several new vaccine submissions. In addition to this, you will also find major surveillance reports and work relevant to Indigenous programs. For clinical and epidemiological research, included are further developments of modelling capacity and significant expansion of clinical trials, including a challenging trial of antiviral use in influenza outbreaks in nursing home settings.

 

Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2003 to 2006.

This is the second NCIRS publication focussing on Aboriginal and Torres Strait Islander people. It includes the latest detailed data on 9 major vaccine preventable diseases, as well as vaccination coverage in children and adults. This publication is now available at the Communicable Diseases Intelligence website at http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi32suppl.htm

TGA statement on Gardasil adverse events

On December 6th 2007, the Theraputic Goods Administration released a summary of reported adverse events following the distribution of over 2.2 million doses of the human papillomavirus vaccine in Australia. To view this statement, click on link

http://www.tga.gov.au/alerts/medicines/gardasil.htm

Release of Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005 publication

NCIRS is proud to announce the publication of Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005, which is the fourth national report into Australia’s progress in preventing diseases through vaccination.

The report provides an overview of the 16 diseases preventable by currently available vaccines. These include the 12 for which vaccines were funded nationally for children by the end of 2005 (diphtheria, Haemophilus influenzae type b (Hib) disease, hepatitis B, invasive pneumococcal disease, measles, meningococcal C disease, mumps, pertussis, poliomyelitis, rubella, tetanus and varicella), and another 3 vaccines only funded or recommended for specific high-risk groups (hepatitis A, influenza and Q fever). Rotavirus, for which new vaccines became available in 2006, is also included.

The report can be found at the Communicable Diseases Intelligence website
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi31suppl.htm

 

Events

Preventing Cervical Cancer: Integrating Screening and Vaccination - Conference Announcement

The Victorian Cytology Service Inc (VCS), in association with the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), is proud to be the organiser of Preventing Cervical Cancer 2009: Integrating screening and vaccination (PCC2009)

PCC2009 will bring together international and Australian experts in cervical screening, vaccination and cancer epidemiology to debate and explore current and future directions in the prevention of cervical cancer. It will provide a forum for these experts to share their vision and influence policy development in the prevention of cervical cancer.

Australia’s cervical screening program is amongst the most successful in the world. Now, coupled with our world-leading commitment to population-based vaccination for high-risk HPV, Australia is poised to develop highly effective new models for cervical cancer prevention that could eventually lead to the almost total eradication of this disease.

The provisional program is now available at http://www.pcc2009.org.au/program.html

Early bird registration is available until December 24th.

For more information, and registration details, please visit the conference website at www.pcc2009.org.au

 

 

SEMINAR: Developing and communicating about immunisation policy - the bit we don't talk about - September 2007

This seminar was given by Professor David M Salisbury CB FRCP FRCPCH FFPH, Director of Immunisation, Department of Health, United Kingdom.

Summary
The development of immunisation policy in the UK is similar to the model of other industrialised countries: an independent expert advisory committee reviews evidence that it receives, makes recommendations to the Government and these are applied throughout the UK. Where there are differences are in the arrangements for management of the programme.

A team of around 20 individuals within the Department of Health manages the strategy development and implementation. Their work spans the bringing together of scientific evidence, the purchase, supply and distribution arrangements for vaccines, the informatics systems for the immunisation programme and the communications work that informs and supports immunisation implementation.

The UK programme uses the usual process and outcome measurements that are routine (coverage and disease surveillance) but also monitors public knowledge and attitudes about immunisation with equal priority. Given the extent of investment especially in new vaccines, it is of increasing importance that consumer attitudes are monitored and reflected in programme management. This aspect of programme management requires skills specific to the task and that should be integral within national programmes.

A copy of Professor Salisbury's PowerPoint slides is available here: presentation.

 

Communicable Diseases Control Conference - March 2007

NCIRS staff presented a number of posters at the recent CDC conference in Canberra. The biennial national conference is held under the auspices of the Communicable Diseases Network Australia and the Public Health Laboratory Network. PDF copies of the posters can be accessed below:

Pandemic Influenza: Sydney Business Leaders discuss the possible Impact in a Focus Group - Ralf Itzwerth

An earlier 2nd dose of MMR? Insights from modelling… - James Wood

Pertussis epidemiology in Australia over the decade 1995-2005: trends by region and age group - Helen Quinn

Age-specific trends in varicella hospitalisations in Australia prior to a universally funded program - Anita Heywood

 

IX International Symposium on Respiratory Viral Infections - March 2007

NCIRS staff presented a number of posters at this recent conference in Hong Kong. PDF copies of the posters can be accessed below:

Active surveillance and early intervention with oseltamivir for controlling influenza outbreaks in aged care facilities - Clayton Chiu

An Outbreak of Influenza B at a Chronic Care Psychogeriatric Hospital - Holly Seale


NCIRS Varicella Zoster Virus Workshop 2006

A 2-day workshop on the varicella zoster virus was held in Sydney on the 16-17th November 2006. Prominent international guest speakers included Professor Myron Levin (US), Professor Anne Gershon (US) and Professor Judith Breuer (UK). Presentations from this workshop can be found HERE.

 

More news

Australian Government Funds Rotavirus vaccine (28 March 2007)

The Australian Government will provide $124.4 million over the next five years to include free Rotavirus vaccines on the National Immunisation Program.

Two Rotavirus vaccines will be included on the National Immunisation Program, Rotarix® from GlaxoSmithKline and RotaTeq® from CSL Limited.

The new vaccine will be given orally to babies from two to six months of age, commencing in July 2007. All babies born from 1 May 2007 will be eligible for the free vaccine. Two or three doses, depending on the brand administered, will generally be given at the same time as other immunisations at around two, four and six months of age.
More...

 

NCIRS Newsletter - current and past issues

 

NCIRS Fact sheets

 

NCIRS MMR Decision Aid

 

Breakthrough in TB vaccine?

NCIRS-AIP email discussion list

NCIRS is pleased to announce that there are now over 320 Australian immunisation professionals subscribed to the NCIRS-AIP email discussion list.

NCIRS-AIP is an electronic email discussion group that has been set up for Australian immunisation professionals. This group facilitates communication between Australian immunisation practitioners, policy makers and researchers. It is modelled on a similar group in the UK. Discussion items include:

1. News items/publications and meetingsof interest
2. A forum for questions and feedback
3. An avenue for rapid information aboutmedia controversies.

The group is designed chiefly for professionals involved in immunisation in Australia, whether at the level of research, policy development or as immunisation providers. NCIRS welcomes into the group all Australian professionals, as well as professionals in other countries who wish to learn more about immunisation in Australia, and/or wish to communicate their experience with us.

Subscribers to NCIRS-AIP receive regular international updates on immunisation news (news briefs) and weekly summaries and commentaries on recent papers presented and discussed at the NCIRS Immunisation Journal Club.

If you are interested in subscribing to this group, please log on at http://mailman.ucc.usyd.edu.au/mailman/listinfo/ncirs-aip and follow the instructions located there.

 

Recent NCIRS Journal Club summaries

 

 

home | about | staff | research | the facts | publications | links | news + events | search
Comments or suggestions to the Webmaster webncirs@ncirs.usyd.edu.au
© 2007 NCIRS All rights reserved | Last modified 4 November, 2009